Current research on PD-L2 is still in the initial stage, but the development of a study of PD-L2 and its various receptors will help further explore the effect and mechanism of the tumor immune microenvironment in tumor occurrence and development and provide a new set of therapeutic strategies. The gene discussed is PDCD1LG2; the disease is neoplasm.